Healthcare precision InsightRX operates in hospitals and health care with a focus on precision dosing and clinical decision support, presenting a sales opportunity to expand partnerships with health systems seeking data-driven, individualized treatment capabilities.

Recent platform growth The launch of Apollo Studio in 2026 indicates a pivot toward self-service analytics and natural language interfaces, suggesting upsell potential to existing customers and a path to broader adoption across pharmacy teams.

Commercial partnerships Past and ongoing collaborations with Northern Arizona Healthcare, Healix, and OSF HealthCare demonstrate a track record of integrating InsightRX solutions into clinical workflows, signaling opportunities to expand with additional health systems and infusion networks.

Mid-market focus With 11-50 employees and multi-million revenue, InsightRX sits in a mid-market niche ripe for scalable deployment deals, channel partnerships, and expanded support offerings to mid-sized hospitals and clinics seeking enterprise-grade decision support.

Data-driven expansion The technology stack and cloud-based CDS capabilities position InsightRX to partner with data and IT leaders at potential enterprise customers, offering opportunities to integrate with existing EHR/BI ecosystems and expand analytics-driven dosing programs.